Aktien Sensor

Johnson & Johnson plans to invest $55 billion in the US over four years, shifting its focus to domestic production and driving innovation in manufacturing, research, and technology.

Johnson & Johnson plans to invest $55 billion in the US over four years, a move aimed at reducing reliance on foreign production and staying ahead of the competition, but its success is uncertain.

Johnson & Johnson plans to invest $55 billion in the US over the next four years, with a focus on manufacturing, research, and technology, in response to import tariffs and to boost the US economy.

Johnson & Johnson is attempting to push through a multi-billion-dollar settlement for claims its baby powder caused ovarian cancer, but critics argue the company is trying to manipulate the system to avoid accountability.

Johnson & Johnson is selling its Cerenovus stroke care business for $1 billion to $1.5 billion, raising questions about the company’s commitment to innovation and the future of stroke care.